On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Microsoft has released Windows 10 KB5120249 Extended Security Updates for versions 22H2 and 21H2 to fix security vulnerabilities and bugs. Today is Microsoft's August 2026 Patch Tuesday, and with it ...

The Windows operating system allows you to pin most software or apps directly to the taskbar for quick access when you’re on the desktop. This, however, does not hold true for Windows Update. While it ...

Treasury Secretary Scott Bessent is reinventing the government’s role in the world’s most important bond market. 5 min read Bond Market Stress Returns and Oil Rises in Edgy Day for Markets 3 min read ...

Access detailed historical stock prices, including daily closing prices, for RXRX. Analyze past performance trends, track price movements, and explore historical data to inform your investment ...

View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...